These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37684045)

  • 1. Huntingtin loss in hepatocytes is associated with altered metabolism, adhesion, and liver zonation.
    Bragg RM; Coffey SR; Cantle JP; Hu S; Singh S; Legg SR; McHugh CA; Toor A; Zeitlin SO; Kwak S; Howland D; Vogt TF; Monga SP; Carroll JB
    Life Sci Alliance; 2023 Nov; 6(11):. PubMed ID: 37684045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huntingtin loss in hepatocytes is associated with altered metabolism, adhesion, and liver zonation.
    Bragg RM; Coffey SR; Cantle JP; Hu S; Singh S; Legg SRW; McHugh CA; Toor A; Zeitlin SO; Kwak S; Howland D; Vogt TF; Monga SP; Carroll JB
    bioRxiv; 2023 Jun; ():. PubMed ID: 37425835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington's disease mice.
    Dickson E; Soylu-Kucharz R; Petersén Å; Björkqvist M
    Mol Metab; 2022 Mar; 57():101439. PubMed ID: 35007790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems.
    Soto-Gutierrez A; Gough A; Vernetti LA; Taylor DL; Monga SP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1605-1616. PubMed ID: 28467181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription dynamics in a physiological process: β-catenin signaling directs liver metabolic zonation.
    Torre C; Perret C; Colnot S
    Int J Biochem Cell Biol; 2011 Feb; 43(2):271-8. PubMed ID: 19914393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiocrine Wnt signaling controls liver growth and metabolic maturation in mice.
    Leibing T; Géraud C; Augustin I; Boutros M; Augustin HG; Okun JG; Langhans CD; Zierow J; Wohlfeil SA; Olsavszky V; Schledzewski K; Goerdt S; Koch PS
    Hepatology; 2018 Aug; 68(2):707-722. PubMed ID: 29059455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled Functional Zonation of Hepatocytes
    Wahlicht T; Vièyres G; Bruns SA; Meumann N; Büning H; Hauser H; Schmitz I; Pietschmann T; Wirth D
    ACS Synth Biol; 2020 Jul; 9(7):1638-1649. PubMed ID: 32551516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype onset in Huntington's disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin gene.
    Franich NR; Hickey MA; Zhu C; Osborne GF; Ali N; Chu T; Bove NH; Lemesre V; Lerner RP; Zeitlin SO; Howland D; Neueder A; Landles C; Bates GP; Chesselet MF
    J Neurosci Res; 2019 Dec; 97(12):1590-1605. PubMed ID: 31282030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell fate analysis of zone 3 hepatocytes in liver injury and tumorigenesis.
    Kurosaki S; Nakagawa H; Hayata Y; Kawamura S; Matsushita Y; Yamada T; Uchino K; Hayakawa Y; Suzuki N; Hata M; Tsuboi M; Kinoshita H; Tanaka Y; Nakatsuka T; Hirata Y; Tateishi K; Koike K
    JHEP Rep; 2021 Aug; 3(4):100315. PubMed ID: 34345813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay Between GH-regulated, Sex-biased Liver Transcriptome and Hepatic Zonation Revealed by Single-Nucleus RNA Sequencing.
    Goldfarb CN; Karri K; Pyatkov M; Waxman DJ
    Endocrinology; 2022 Jul; 163(7):. PubMed ID: 35512247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
    Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
    Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.
    Mehler MF; Petronglo JR; Arteaga-Bracho EE; Gulinello ME; Winchester ML; Pichamoorthy N; Young SK; DeJesus CD; Ishtiaq H; Gokhan S; Molero AE
    J Neurosci; 2019 Mar; 39(10):1892-1909. PubMed ID: 30626701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C viral proteins perturb metabolic liver zonation.
    Moreau M; Rivière B; Vegna S; Aoun M; Gard C; Ramos J; Assenat E; Hibner U
    J Hepatol; 2015 Feb; 62(2):278-85. PubMed ID: 25220251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Gpr52 lowers mutant HTT levels and rescues Huntington's disease-associated phenotypes.
    Song H; Li H; Guo S; Pan Y; Fu Y; Zhou Z; Li Z; Wen X; Sun X; He B; Gu H; Zhao Q; Wang C; An P; Luo S; Hu Y; Xie X; Lu B
    Brain; 2018 Jun; 141(6):1782-1798. PubMed ID: 29608652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic.
    Miniarikova J; Evers MM; Konstantinova P
    Mol Ther; 2018 Apr; 26(4):947-962. PubMed ID: 29503201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial Wnts regulate β-catenin signaling in murine liver zonation and regeneration: A sequel to the Wnt-Wnt situation.
    Preziosi M; Okabe H; Poddar M; Singh S; Monga SP
    Hepatol Commun; 2018 Jul; 2(7):845-860. PubMed ID: 30027142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huntingtin-Lowering Therapies for Huntington Disease: A Review of the Evidence of Potential Benefits and Risks.
    Leavitt BR; Kordasiewicz HB; Schobel SA
    JAMA Neurol; 2020 Jun; 77(6):764-772. PubMed ID: 32202594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation.
    Träger U; Andre R; Lahiri N; Magnusson-Lind A; Weiss A; Grueninger S; McKinnon C; Sirinathsinghji E; Kahlon S; Pfister EL; Moser R; Hummerich H; Antoniou M; Bates GP; Luthi-Carter R; Lowdell MW; Björkqvist M; Ostroff GR; Aronin N; Tabrizi SJ
    Brain; 2014 Mar; 137(Pt 3):819-33. PubMed ID: 24459107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection by dietary restriction in the YAC128 mouse model of Huntington's disease: Relation to genes regulating histone acetylation and HTT.
    Moreno CL; Ehrlich ME; Mobbs CV
    Neurobiol Dis; 2016 Jan; 85():25-34. PubMed ID: 26485309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocyte transduction is required for rescue of behavioral phenotypes in the YAC128 mouse model with AAV-RNAi mediated HTT lowering therapeutics.
    Stanek LM; Bu J; Shihabuddin LS
    Neurobiol Dis; 2019 Sep; 129():29-37. PubMed ID: 31042572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.